IRIS PubliCatt

Metafuni, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.761
NA - Nord America 1.637
AS - Asia 722
AF - Africa 24
SA - Sud America 11
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.615
DE - Germania 466
SE - Svezia 400
IT - Italia 331
SG - Singapore 273
CN - Cina 272
IE - Irlanda 118
FR - Francia 107
ID - Indonesia 81
GB - Regno Unito 80
UA - Ucraina 71
FI - Finlandia 65
RU - Federazione Russa 47
IN - India 34
CA - Canada 21
CI - Costa d'Avorio 21
TR - Turchia 18
BE - Belgio 17
CZ - Repubblica Ceca 15
HK - Hong Kong 14
TH - Thailandia 7
AT - Austria 6
ES - Italia 6
KR - Corea 6
NL - Olanda 6
CO - Colombia 4
BR - Brasile 3
PT - Portogallo 3
RO - Romania 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LI - Liechtenstein 2
LV - Lettonia 2
NO - Norvegia 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
HR - Croazia 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
VN - Vietnam 1
Totale 4.158
Salva come PNG Salva come JPEG
Città #
Chandler 402
Singapore 210
Ashburn 134
Dublin 116
Jakarta 80
San Mateo 68
Rome 64
Jacksonville 62
Houston 49
Nanjing 49
Dearborn 48
Milan 48
Florence 46
Beijing 45
New York 45
Ann Arbor 42
Marseille 42
Moscow 37
Wilmington 36
Los Angeles 34
Helsinki 33
Princeton 33
Lancaster 32
Cattolica 30
Nürnberg 29
Boston 27
Chicago 27
Bremen 26
Munich 26
Nanchang 22
Abidjan 21
Seattle 18
Brussels 17
Santa Clara 17
Lappeenranta 16
Toronto 15
Guangzhou 14
Izmir 14
London 14
Woodbridge 14
Fairfield 13
Lawrence 13
Tianjin 13
Boardman 12
Brno 12
Hong Kong 12
Pune 12
Norwalk 11
Washington 11
Redwood City 10
Augusta 9
Hefei 9
Shanghai 9
Arezzo 8
Mountain View 8
Falkenstein 7
Redmond 7
Shenyang 7
Leawood 6
Seoul 6
Auburn Hills 5
Edinburgh 5
Frankfurt am Main 5
Kunming 5
Nuremberg 5
Paris 5
San Francisco 5
Zhengzhou 5
Bangkok 4
Changsha 4
Columbus 4
Falls Church 4
Fremont 4
Amsterdam 3
Bogotá 3
Bologna 3
Garden City 3
Hangzhou 3
Hebei 3
Jiaxing 3
Naples 3
Ottawa 3
Philadelphia 3
Selargius 3
Stockholm 3
University Park 3
Afragola 2
Bagnacavallo 2
Bagnoli Irpino 2
Bang Bai Mai 2
Berlin 2
Cambridge 2
Clifton 2
Essen 2
Ferrara 2
Fuzhou 2
Jeddah 2
Jinan 2
Kemerovo 2
Lanzhou 2
Totale 2.424
Salva come PNG Salva come JPEG
Nome #
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 171
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 138
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 124
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 114
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 103
Hyperleukocytosis and leukostasis: management of a medical emergency 103
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 100
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 100
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 97
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 89
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 87
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 83
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 78
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 77
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 75
Changes in protein serum levels during stem cell transplantation 73
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 69
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 69
Unrelated cord blood transplantation and post-transplant cyclophosphamide 67
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 67
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 67
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 67
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 66
Unrelated cord blood transplantation and post-transplant cyclophosphamide 64
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 64
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 64
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 62
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 62
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 61
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 61
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 60
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 50
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 49
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 47
Reducing infectious complications after allogeneic stem cell transplant 45
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 45
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 43
Second haploidentical stem cell transplantation for primary graft failure 43
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 42
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 41
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 39
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 38
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 37
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 35
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 33
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 31
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 31
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 31
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 31
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 30
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 29
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 27
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 24
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 24
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 23
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 22
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 22
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 21
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 21
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 20
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 20
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 19
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 19
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 18
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 18
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 17
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 15
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 15
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 15
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 14
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 14
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 13
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 13
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 9
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 9
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 9
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 8
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 6
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 4
Totale 4.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 0 0 0 0 0 36 15 26 36 35 25
2020/2021237 9 19 10 15 20 17 15 12 31 10 72 7
2021/2022488 34 14 29 24 43 12 9 72 19 45 98 89
2022/20231.216 188 159 72 185 85 135 88 84 102 51 54 13
2023/2024776 29 156 45 60 21 94 65 43 17 56 85 105
2024/2025562 47 52 127 101 170 65 0 0 0 0 0 0
Totale 4.287